Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02636530 · ClinicalTrials.gov registry record · NA
Effect of Two Exercise Programs on Bone Strength and Architecture
A NA study of Osteoporosis, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 2
- Study locations
NCT02636530: Completed NA study of Osteoporosis, sponsored by University of Colorado, Denver.
NCT02636530 is a NA study of Osteoporosis that has completed, run by University of Colorado, Denver. The registered enrollment target is 48 participants, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02636530, a NA study of Osteoporosis, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 2
- Study locations
Study Summary
Bone responds according to the load placed on it. In this study, investigators want to know if exercise that loads the body in exercises, like walking or jogging (Ground Reaction Forces: GRF), affects bone differently than exercises that load the joints, like weight lifting (Joint Reaction Forces: JRF). Participants will exercise at least 3 times a week for 6 months. Measures of bone strength and mass, muscular strength, and aerobic fitness will be taken at the beginning and the end of the 6 month program. Period blood samples will be taken for future analysis of blood markers.
Primary Outcome
Measured via quantitative computed tomography (QCT)
Conditions Studied
Interventions
- BEHAVIORAL Ground Reaction Forces
- BEHAVIORAL Joint Reaction Forces
Study Locations (2)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
- Veteran's Affairs Eastern Colorado Healthcare System - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
What the finished NCT02636530 record still lists
NCT02636530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,545-participant average among 84 other Osteoporosis trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 2 interventions - of which Ground Reaction Forces is the first listed.
NCT02636530 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02636530 about?
NCT02636530 is a clinical study titled "Effect of Two Exercise Programs on Bone Strength and Architecture". Bone responds according to the load placed on it. In this study, investigators want to know if exercise that loads the body in exercises, like walking or jogging (Ground Reaction Forces: GRF), affects bone differently than exercises that load the joints, like weight lifting (Joint Reaction Forces: J...
What is the current status of trial NCT02636530?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2016-07-01. Estimated completion is 2021-12-01.
What conditions does trial NCT02636530 study?
This clinical trial studies the following conditions: Osteoporosis.
What interventions are being tested in trial NCT02636530?
The interventions under investigation include: Ground Reaction Forces (BEHAVIORAL), Joint Reaction Forces (BEHAVIORAL).
Who is sponsoring clinical trial NCT02636530?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02636530 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02636530's enrollment target sits among peer trials
48 58th of 84 higher than 27 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
RECRUITING · NA
-
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
RECRUITING · NA
-
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RECRUITING · NA
-
Mode of Exercise and Bone Biomarkers in Older Veterans
RECRUITING · NA
-
Synbiotic to Attenuate Resorption of the Skeleton
RECRUITING · NA
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI